Abstract

Circulating tumor cells (CTCs) are recognized as direct seeds of metastasis. However, CTC count may not be the “best” indicator of metastatic risk because their heterogeneity is generally neglected. In this study, we develop a molecular typing system to predict colorectal cancer metastasis potential based on the metabolic fingerprints of single CTCs. After identification of the metabolites potentially related to metastasis using mass spectrometry-based untargeted metabolomics, setup of a home-built single-cell quantitative mass spectrometric platform for target metabolite analysis in individual CTCs and use of a machine learning method composed of non-negative matrix factorization and logistic regression, CTCs are divided into two subgroups, C1 and C2, based on a 4-metabolite fingerprint. Both in vitro and in vivo experiments demonstrate that CTC count in C2 subgroup is closely associated with metastasis incidence. This is an interesting report on the presence of a specific population of CTCs with distinct metastatic potential at the single-cell metabolite level.

Circulating tumor cells (CTCs) are the tumor cells responsible for metastasis. Here, the authors develop a home-built single-cell quantitative mass spectrometric platform and discover a cluster of CTCs with distinct metastatic potential using a molecular typing system based on the single-cell metabolic fingerprints.

Details

Title
Single-cell metabolic fingerprints discover a cluster of circulating tumor cells with distinct metastatic potential
Author
Zhang, Wenjun 1 ; Xu, Feifei 1 ; Yao, Jiang 1 ; Mao, Changfei 2 ; Zhu, Mingchen 3 ; Qian, Moting 1 ; Hu, Jun 1 ; Zhong, Huilin 4 ; Zhou, Junsheng 4 ; Shi, Xiaoyu 1 ; Chen, Yun 5   VIAFID ORCID Logo 

 Nanjing Medical University, School of Pharmacy, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984) 
 Jiangsu Cancer Hospital (Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital), Department of General Surgery, Nanjing, China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566) 
 Jiangsu Cancer Hospital (Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital), Department of Clinical Laboratory, Nanjing, China (GRID:grid.452509.f) (ISNI:0000 0004 1764 4566) 
 Nanjing Normal University, School of Computer Science and Technology, Nanjing, China (GRID:grid.260474.3) (ISNI:0000 0001 0089 5711) 
 Nanjing Medical University, School of Pharmacy, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984); State Key Laboratory of Reproductive Medicine, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984); Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Nanjing, China (GRID:grid.89957.3a) 
Pages
2485
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2807562974
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.